More medical news from Reuters Health News
Many U.S. kids with brain injuries not getting needed rehab
Reuters Health News : April 20, 2018, 12:16 pm
(Reuters Health) - Many children hospitalized in the U.S. for brain injuries don't receive all the rehabilitation services needed for them to potentially make a full recovery, a new study suggests.
U.S. biotech companies Alnylam, Dicerna settle trade secrets case
Reuters Health News : April 20, 2018, 10:55 am
BOSTON (Reuters) - Alnylam Pharmaceuticals Inc said on Friday that Dicerna Pharmaceuticals Inc will pay it $25 million in cash and stock to resolve a lawsuit claiming it stole trade secrets about gene-silencing technology used to develop drug treatments.
Losing a spouse late in life linked to cognitive decline
Reuters Health News : April 20, 2018, 7:42 am
(Reuters Health) - Older adults who lose a spouse may be more vulnerable to cognitive decline in subsequent years and require extra support and monitoring, researchers say.
Germany's Merck seeks partners for cancer and immune system drugs
Reuters Health News : April 20, 2018, 6:14 am
FRANKFURT (Reuters) - Merck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing deals to help fund clinical trials, according to its head of drug R&D.
Biogen boosts investment in neurology with $1 billion Ionis deal
Reuters Health News : April 20, 2018, 5:04 am
(Reuters) - U.S. drugmaker Biogen Inc rolled out part of its $37 billion investment warchest on Friday, signing a $1 billion deal that seeks to expand on the strength of an existing partnership with Ionis Pharmaceuticals Inc.